DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery
NCT04281862
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Refractive Surgery
Interventions
DRUG:
Dextenza 0.4Mg Ophthalmic Insert
DRUG:
Topical Prednisolone
Sponsor
Vance Thompson Vision